Advertisement

Dilated Cardiomyopathy

  • Eun Young Kim
  • Yeon Hyeon ChoeEmail author
Chapter
  • 2.4k Downloads

Abstract

Dilated cardiomyopathy (DCM) is a progressive disease of heart muscle that is characterized by ventricular chamber enlargement and contractile dysfunction, and DCM is the third most common cause of heart failure and the most frequent reason for heart transplantation. Cardiac MR is useful modality for the diagnosis, and to assess the degree of cardiac dysfunction, to identify the cause, and to guide treatment.

Keywords

Late Gadolinium Enhancement Aortic Valve Disease Restrictive Cardiomyopathy Diffuse Fibrosis Left Ventricle Chamber 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

311690_1_En_13_MOESM1_ESM.avi (1.7 mb)
Video 13.1 (AVI 1715 kb)
311690_1_En_13_MOESM2_ESM.avi (1.1 mb)
Video 13.2 (AVI 1111 kb)
311690_1_En_13_MOESM3_ESM.avi (1.5 mb)
Video 13.3 (AVI 1577 kb)
311690_1_En_13_MOESM4_ESM.avi (1.6 mb)
Video 13.4 (AVI 1612 kb)
Video 13.5

(AVI 3106 kb)

References

  1. 1.
    Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807–16.CrossRefPubMedGoogle Scholar
  2. 2.
    Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996;93:841–2.CrossRefPubMedGoogle Scholar
  3. 3.
    Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med. 1994;331:1564–75.CrossRefPubMedGoogle Scholar
  4. 4.
    McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997;350:829–33.CrossRefPubMedGoogle Scholar
  5. 5.
    Devereux RB, Roman MJ, Paranicas M, et al. A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study. Am Heart J. 2001;141:439–46.CrossRefPubMedGoogle Scholar
  6. 6.
    Giesbrandt KJ, Bolan CW, Shapiro BP, Edwards WD, Mergo PJ. Diffuse diseases of the myocardium: MRI-pathologic review of cardiomyopathies with dilatation. AJR Am J Roentgenol. 2013;200:W274–82.CrossRefPubMedGoogle Scholar
  7. 7.
    O’Donnell DH, Abbara S, Chaithiraphan V, et al. Cardiac MR imaging of nonischemic cardiomyopathies: imaging protocols and spectra of appearances. Radiology. 2012;262:403–22.CrossRefPubMedGoogle Scholar
  8. 8.
    Belloni E, De Cobelli F, Esposito A, et al. MRI of cardiomyopathy. AJR Am J Roentgenol. 2008;191:1702–10.CrossRefPubMedGoogle Scholar
  9. 9.
    Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48:1977–85.CrossRefPubMedGoogle Scholar
  10. 10.
    Sibley CT, Noureldin RA, Gai N, et al. T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology. 2012;265:724–32.CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Department of RadiologyGachon University Gil HospitalIncheonRepublic of Korea
  2. 2.Department of RadiologySamsung Medical Center, Sungkyunkwan University School of MedicineSeoulRepublic of Korea

Personalised recommendations